[시장보고서]주사용 약물전달 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

주사용 약물전달 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Injectable Drug Delivery Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

상품코드 : 1684473

리서치사 : Persistence Market Research

발행일 : 2025년 03월

페이지 정보 : 영문 194 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,418,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,834,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,616,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

Persistence Market Research는 이번에 세계의 주사용 약물전달 시장에 관한 종합 보고서를 발표했습니다. 시장 성장 촉진요인·동향·기회·촉진요인·과제 등 중요한 시장 역학을 철저하게 평가하고, 시장 구조에 관한 상세 인사이트를 제공하고 있습니다. 이 조사 리포트는 2025-2032년 세계 주사용 약물전달 시장의 예측 성장 궤도를 설명하는 독점 데이터와 통계를 게재하고 있습니다.

주요 인사이트

주사용 약물전달 시장 규모(2025년) : 7,800억 달러
예측 시장가치(2032년) : 1조 4,101억 달러
세계 시장 성장률(CAGR 2025-2032년) : 8.8%

주사용 약물전달 시장 - 조사 범위 :

주사용 약물전달 시스템은 만성질환 관리, 응급의료, 백신 등의 약물 투여에 필수적입니다. 이러한 전달 시스템에는 기존 주사기, 프리필드 주사기, 자동 주사기, 무침 주사기 등이 있으며, 정확한 약물 투여와 환자 순응도 향상을 보장합니다. 이 시장은 병원, 클리닉, 재택의료, 외래진료센터 등을 대상으로 치료 결과를 향상시키는 첨단 약물전달 솔루션을 제공합니다. 시장 성장의 원동력은 만성질환 유병률 증가, 생물제제 및 바이오시밀러의 기술 발전, 재택의료에서 자가투여 장비의 채택 증가 등입니다.

시장 성장 촉진요인:

세계 주사제 약물전달 시장은 당뇨병, 암, 자가면역질환과 같은 만성질환 치료에서 생물제제 및 바이오시밀러에 대한 수요 증가 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 자동 주사기, 프리필드 시린지 등 자가 투약 약물전달 시스템의 급속한 확대는 환자의 편의성과 복약 순응도를 향상시키고 있습니다. 또한 정신건강 치료 및 통증 관리에서 장시간 지속되는 주사제의 사용이 증가하면서 시장 성장에 기여하고 있습니다. 마이크로니들 패치 및 스마트 인젝터와 같은 기술의 발전은 약물의 생체 이용률을 향상시키고 주사시 통증을 감소시킴으로써 업계에 혁명을 일으키고 있습니다. 특히 감염성 질환 및 소아 예방접종 등 전 세계 예방접종 프로그램의 확대는 시장 확대를 더욱 가속화하고 있습니다.

시장 성장 억제요인:

주사제 약물전달 시장은 높은 성장세가 예상되지만, 높은 제조 비용, 엄격한 규제 요건, 주사침 자상 사고에 대한 우려 등의 문제에 직면해 있습니다. 생물제제의 제형화 및 안정성에 따른 복잡성은 종종 개발 및 제조 비용의 상승을 초래합니다. 또한 주사기 및 약품의 적합성에 대한 엄격한 규제는 신제품 시장 진입을 지연시킬 수 있습니다. 감염의 위험과 사용한 주사기의 부적절한 폐기 등 안전에 대한 우려는 주사바늘을 사용하지 않는 기술 개발 및 폐기 방법의 개선이 요구되는 또 다른 과제입니다.

시장 기회:

주사제 약물전달 시장은 약물 제형과 전달 메커니즘의 혁신으로 인해 큰 비즈니스 기회를 창출하고 있습니다. 지속적인 약물전달을 위한 웨어러블 주사기의 채택이 증가하고 있으며, 용량 추적 및 원격 모니터링을 위한 스마트 기술의 통합이 시장을 변화시키고 있습니다. 종양학 및 면역 요법 분야에서 바이오시밀러 및 생물제제에 대한 수요 증가는 유리한 성장 경로를 보여주고 있습니다. 또한 백신 접종 프로그램 및 자가 투약 약물 요법을 장려하는 정부의 구상은 새로운 시장 기회를 창출하고 있습니다. 제약회사와 의료기기 제조업체의 전략적 제휴는 차세대 주사제 개발을 촉진할 것으로 예상됩니다.

이 보고서에서 다룬 주요 질문

주사제 약물전달 시장의 세계 성장을 가속하는 주요 요인은 무엇인가?
제약업계에서 각광받고 있는 약물전달 시스템은?
기술 발전은 주사제 약물전달 시장 경쟁 구도를 어떻게 변화시키고 있는가?
시장에 기여하는 주요 기업은 어디에 있으며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
세계 주사제 약물전달 시장의 새로운 동향과 전망은?

주요 하이라이트
- 시장 규모와 전년대비 성장률
- 절대적 매출 기회
시장 규모 분석과 예측
- 과거 시장 규모 분석, 2019-2024년
- 현재 시장 규모 분석과 예측, 2025-2032년
세계의 주사용 약물전달 시장 전망 : 제품
- 서론/주요 조사 결과
- 과거 시장 규모 분석, 제품별, 2019-2023년
- 현재 시장 규모 분석과 예측, 제품별, 2025-2032년
  - 자기 주사기
    - 싱글 챔버 자기 주사기
    - 듀얼 챔버 자기 주사기
  - 무바늘 주사기
    - 프리필드 무바늘 주사기
    - 충전 가능한 무바늘 주사기
  - 자동 주사기
    - 프리필드 자동 주사기
    - 충전 가능한 자동 주사기
  - 웨어러블 주사기
    - 웨어러블 패치 주사기
    - 체외 장착형 주사기
  - 인슐린 펜
    - 재사용 가능 인슐린 펜
    - 일회용 인슐린 펜
    - 스마트 인슐린 펜
- 시장의 매력 분석 : 제품
세계의 주사용 약물전달 시장 전망 : 테크놀러지
- 서론/주요 조사 결과
- 과거 시장 규모 분석, 테크놀러지별, 2019-2023년
- 현재 시장 규모 분석과 예측, 테크놀러지별, 2025-2032년
  - 비스마트 주사기
  - 스마트 주사기
    - 인공지능(AI)과 기계학습의 통합
    - 근거리 무선통신(NFC)
    - 클라우드 컴퓨팅
    - Bluetooth
- 시장의 매력 분석 : 테크놀러지
세계의 주사용 약물전달 시장 전망 : 사용 상황
- 서론/주요 조사 결과
- 과거 시장 규모 분석, 사용 상황별, 2019-2023년
- 현재 시장 규모 분석과 예측, 사용 상황별, 2025-2032년
  - 일회용 주사기
  - 재사용 가능주사기
- 시장의 매력 분석 : 사용 상황
세계의 주사용 약물전달 시장 전망 : 적응증
- 서론/주요 조사 결과
- 과거 시장 규모 분석, 적응증별, 2019-2023년
- 현재 시장 규모 분석과 예측, 적응증별, 2025-2032년
  - 아나필락시스
  - 당뇨병
  - 심혈관질환
  - 다발성 경화증
  - 류마티스 관절염
  - 암
  - 외상과 응급
  - 기타
- 시장의 매력 분석 : 적응증
세계의 주사용 약물전달 시장 전망 : 유통 채널
- 서론/주요 조사 결과
- 과거 시장 규모 분석, 유통 채널별, 2019-2023년
- 현재 시장 규모 분석과 예측, 유통 채널별, 2025-2032년
  - 병원 약국
  - 드러그스토어
  - 소매 약국
  - 온라인 약국
- 시장의 매력 분석 : 유통 채널

제5장 세계의 주사용 약물전달 시장 전망 : 지역

주요 하이라이트
과거 시장 규모 분석, 지역별, 2019-2023년　
현재 시장 규모 분석과 예측, 지역별, 2025-2032년
- 북미
- 유럽
- 동아시아
- 남아시아와 오세아니아
- 라틴아메리카
- 중동 및 아프리카
시장의 매력 분석 : 지역

제6장 북미의 주사용 약물전달 시장 전망

제7장 유럽의 주사용 약물전달 시장 전망

제8장 동아시아의 주사용 약물전달 시장 전망

제9장 남아시아 및 오세아니아의 주사용 약물전달 시장 전망

제10장 라틴아메리카의 주사용 약물전달 시장 전망

제11장 중동 및 아프리카의 주사용 약물전달 시장 전망

제12장 경쟁 구도

시장 점유율 분석, 2025년
시장 구조
- 시장별 경쟁 격화 맵
- 경쟁 대시보드
기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
- Eli Lilly and Company
- Biocon
- Becton, Dickinson &Company
- West Pharmaceutical Services, Inc.
- Johnson &Johnson
- Antares Pharma
- AbbVie Inc.
- Pfizer Inc.
- Mylan NV
- Vetter Pharma-Fertigung GmbH &Co.KG
- Emperra GmbH
- Digital Medics Pty Ltd
- Enable Injections LLC
- Insulet corporation
- Consort Medical Plc.
- Diabnext
- Diamesco Co., Ltd
- SCHOTT AG(Schott Kaisha Pvt. Ltd.)
- SiO2 Medical Products
- Integrity Bio, Inc.
- Wilhelm Haselmeier GmbH &Co. KG
- Tandem Diabetes Care
- Sanofi SA
- Companion Medical Inc.
- Ypsomed
- F. Hoffman-La Roche Ltd.
- Novo Nordisk A/S
- Medtronic Plc.

제13장 부록

조사 방법
조사의 전제
두자어와 약어

KSA

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for injectable drug delivery. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global injectable drug delivery market from 2025 to 2032.

Key Insights:

Injectable Drug Delivery Market Size (2025E): US$ 780 Bn
Projected Market Value (2032F): US$ 1410.1 Bn
Global Market Growth Rate (CAGR 2025 to 2032): 8.8%

Injectable Drug Delivery Market - Report Scope:

Injectable drug delivery systems are critical for the administration of medications in chronic disease management, emergency medicine, and vaccines. These delivery systems include conventional syringes, prefilled syringes, autoinjectors, and needle-free injectors, which ensure precise drug dosing and improved patient compliance. The market caters to hospitals, clinics, home healthcare, and ambulatory care centers, offering advanced drug delivery solutions that enhance therapeutic outcomes. Market growth is driven by the rising prevalence of chronic diseases, technological advancements in biologics and biosimilars, and the increasing adoption of self-administration devices for home care.

Market Growth Drivers:

The global injectable drug delivery market is propelled by several key factors, including the growing demand for biologics and biosimilars in treating chronic diseases such as diabetes, cancer, and autoimmune disorders. The rapid expansion of self-administration drug delivery systems, such as autoinjectors and prefilled syringes, is enhancing patient convenience and compliance. Furthermore, the increasing use of long-acting injectables in mental health treatment and pain management is contributing to market growth. Technological advancements, such as microneedle patches and smart injectors, are revolutionizing the industry by improving drug bioavailability and reducing injection pain. The expansion of vaccination programs worldwide, particularly for infectious diseases and pediatric immunizations, further accelerates market expansion.

Market Restraints:

Despite strong growth prospects, the injectable drug delivery market faces challenges, including high production costs, stringent regulatory requirements, and concerns regarding needle-stick injuries. The complexities associated with biologic drug formulation and stability often result in increased development and manufacturing costs. Additionally, strict regulations governing injectable devices and drug compatibility can delay market entry for new products. Safety concerns, including the risk of infections and improper disposal of used injectables, pose further challenges, necessitating the development of needle-free technologies and improved disposal mechanisms.

Market Opportunities:

The injectable drug delivery market presents significant opportunities driven by innovation in drug formulations and delivery mechanisms. The increasing adoption of wearable injectors for continuous drug delivery and the integration of smart technology for dose tracking and remote monitoring are transforming the market. The rising demand for biosimilars and biologics in oncology and immunotherapy presents a lucrative growth avenue. Additionally, government initiatives promoting vaccination programs and self-administration drug therapies create new market opportunities. Strategic collaborations between pharmaceutical companies and medical device manufacturers are expected to drive the development of next-generation injectable solutions.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the injectable drug delivery market globally?
Which drug delivery systems are gaining prominence in the pharmaceutical industry?
How are technological advancements reshaping the competitive landscape of the injectable drug delivery market?
Who are the key players contributing to the market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global injectable drug delivery market?

Competitive Intelligence and Business Strategy:

Leading players in the global injectable drug delivery market, including Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, and Pfizer Inc., are focusing on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce advanced delivery solutions such as needle-free injectors, smart syringes, and biodegradable drug delivery systems. Collaborations with biotech firms and regulatory agencies facilitate market access and regulatory compliance. Moreover, emphasis on patient-centric drug delivery systems, safety enhancements, and sustainability initiatives is shaping the future of the market.

Key Companies Profiled:

Becton, Dickinson and Company
Gerresheimer AG
Eli Lilly and Company
Pfizer Inc.
Ypsomed AG
West Pharmaceutical Services, Inc.
Schott AG
Novo Nordisk A/S
Terumo Corporation
Baxter International Inc.

Injectable Drug Delivery Market Segmentation

By Product

Self-injectors
Needle Free Injectors
Auto Injectors
Wearable Injectors

By Technology

Non-smart Injectors
Smart Injectors

By Usage

Disposable
Reusable

By Indication

Anaphylaxis
Diabetes
Cardiovascular Diseases
Multiple Sclerosis
Rheumatoid Arthritis
Cancer
Trauma and Emergency

By Distribution Channel

Hospital Pharmacies
Drug Stores
Online Pharmacies
Retail Pharmacies

By Region

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

1. Executive Summary

1.1. Global Injectable Drug Delivery Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis

4. Global Injectable Drug Delivery Market Outlook

4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global Injectable Drug Delivery Market Outlook: Product
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019 - 2023
- 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
  - 4.3.3.1. Self-Injectors
    - 4.3.3.1.1. Single Chamber Self Injectors
    - 4.3.3.1.2. Dual Chamber Self Injectors
  - 4.3.3.2. Needle Free Injectors
    - 4.3.3.2.1. Pre-filled Needle Free Injectors
    - 4.3.3.2.2. Fill-able Needle free Injectors
  - 4.3.3.3. Auto Injectors
    - 4.3.3.3.1. Prefilled Auto Injectors
    - 4.3.3.3.2. Fill-Able Auto Injectors
  - 4.3.3.4. Wearable Injectors
    - 4.3.3.4.1. Wearable Patch Injectors
    - 4.3.3.4.2. Off-body Worn Injectors
  - 4.3.3.5. Insulin Pens
    - 4.3.3.5.1. Reusable Insulin Pens
    - 4.3.3.5.2. Disposable Insulin Pens
    - 4.3.3.5.3. Smart Insulin Pens
- 4.3.4. Market Attractiveness Analysis: Product
4.4. Global Injectable Drug Delivery Market Outlook: Technology
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019 - 2023
- 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
  - 4.4.3.1. Non-Smart Injectors
  - 4.4.3.2. Smart Injectors
    - 4.4.3.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
    - 4.4.3.2.2. Near Filed Communication (NFC)
    - 4.4.3.2.3. Cloud Computing
    - 4.4.3.2.4. Bluetooth
- 4.4.4. Market Attractiveness Analysis: Technology
4.5. Global Injectable Drug Delivery Market Outlook: Usage
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By Usage, 2019 - 2023
- 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Usage, 2025 - 2032
  - 4.5.3.1. Disposable Injectors
  - 4.5.3.2. Reusable Injectors
- 4.5.4. Market Attractiveness Analysis: Usage
4.6. Global Injectable Drug Delivery Market Outlook: Indication
- 4.6.1. Introduction / Key Findings
- 4.6.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019 - 2023
- 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
  - 4.6.3.1. Anaphylaxis
  - 4.6.3.2. Diabetes
  - 4.6.3.3. Cardiovascular Diseases
  - 4.6.3.4. Multiple Sclerosis
  - 4.6.3.5. Rheumatoid Arthritis
  - 4.6.3.6. Cancer
  - 4.6.3.7. Trauma and Emergency
  - 4.6.3.8. Others
- 4.6.4. Market Attractiveness Analysis: Indication
4.7. Global Injectable Drug Delivery Market Outlook: Distribution Channel
- 4.7.1. Introduction / Key Findings
- 4.7.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019 - 2023
- 4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
  - 4.7.3.1. Hospital Pharmacies
  - 4.7.3.2. Drug Stores
  - 4.7.3.3. Retail Pharmacies
  - 4.7.3.4. Online Pharmacies
- 4.7.4. Market Attractiveness Analysis: Distribution Channel

5. Global Injectable Drug Delivery Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 - 2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Injectable Drug Delivery Market Outlook

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 6.2.1. By Country
- 6.2.2. By Product
- 6.2.3. By Technology
- 6.2.4. By Usage
- 6.2.5. By Indication
- 6.2.6. By Distribution Channel
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
- 6.4.1. Self-Injectors
  - 6.4.1.1. Single Chamber Self Injectors
  - 6.4.1.2. Dual Chamber Self Injectors
- 6.4.2. Needle Free Injectors
  - 6.4.2.1. Pre Filled Needle Free Injectors
  - 6.4.2.2. Fill-Able Needle free Injectors
- 6.4.3. Auto Injectors
  - 6.4.3.1. Prefilled Auto Injectors
  - 6.4.3.2. Fill-Able Auto Injectors
- 6.4.4. Wearable Injectors
  - 6.4.4.1. Wearable Patch Injectors
  - 6.4.4.2. Off-body Worn Injectors
- 6.4.5. Insulin Pens
  - 6.4.5.1. Reusable Insulin Pens
  - 6.4.5.2. Disposable Insulin Pens
  - 6.4.5.3. Smart Insulin Pens
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
- 6.5.1. Non-Smart Injectors
- 6.5.2. Smart Injectors
  - 6.5.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
  - 6.5.2.2. Near Filed Communication (NFC)
  - 6.5.2.3. Cloud Computing
  - 6.5.2.4. Bluetooth
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Usage, 2025 - 2032
- 6.6.1. Disposable Injectors
- 6.6.2. Reusable Injectors
6.7. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
- 6.7.1. Anaphylaxis
- 6.7.2. Diabetes
- 6.7.3. Cardiovascular Diseases
- 6.7.4. Multiple Sclerosis
- 6.7.5. Rheumatoid Arthritis
- 6.7.6. Cancer
- 6.7.7. Trauma and Emergency
- 6.7.8. Others
6.8. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
- 6.8.1. Hospital Pharmacies
- 6.8.2. Drug Stores
- 6.8.3. Retail Pharmacies
- 6.8.4. Online Pharmacies
6.9. Market Attractiveness Analysis

7. Europe Injectable Drug Delivery Market Outlook

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Technology
- 7.2.4. By Usage
- 7.2.5. By Indication
- 7.2.6. By Distribution Channel
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
- 7.4.1. Self-Injectors
  - 7.4.1.1. Single Chamber Self Injectors
  - 7.4.1.2. Dual Chamber Self Injectors
- 7.4.2. Needle Free Injectors
  - 7.4.2.1. Pre Filled Needle Free Injectors
  - 7.4.2.2. Fill-Able Needle free Injectors
- 7.4.3. Auto Injectors
  - 7.4.3.1. Prefilled Auto Injectors
  - 7.4.3.2. Fill-Able Auto Injectors
- 7.4.4. Wearable Injectors
  - 7.4.4.1. Wearable Patch Injectors
  - 7.4.4.2. Off-body Worn Injectors
- 7.4.5. Insulin Pens
  - 7.4.5.1. Reusable Insulin Pens
  - 7.4.5.2. Disposable Insulin Pens
  - 7.4.5.3. Smart Insulin Pens
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
- 7.5.1. Non-Smart Injectors
- 7.5.2. Smart Injectors
  - 7.5.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
  - 7.5.2.2. Near Filed Communication (NFC)
  - 7.5.2.3. Cloud Computing
  - 7.5.2.4. Bluetooth
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Usage, 2025 - 2032
- 7.6.1. Disposable Injectors
- 7.6.2. Reusable Injectors
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
- 7.7.1. Anaphylaxis
- 7.7.2. Diabetes
- 7.7.3. Cardiovascular Diseases
- 7.7.4. Multiple Sclerosis
- 7.7.5. Rheumatoid Arthritis
- 7.7.6. Cancer
- 7.7.7. Trauma and Emergency
- 7.7.8. Others
7.8. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
- 7.8.1. Hospital Pharmacies
- 7.8.2. Drug Stores
- 7.8.3. Retail Pharmacies
- 7.8.4. Online Pharmacies
7.9. Market Attractiveness Analysis

8. East Asia Injectable Drug Delivery Market Outlook

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Technology
- 8.2.4. By Usage
- 8.2.5. By Indication
- 8.2.6. By Distribution Channel
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
- 8.4.1. Self-Injectors
  - 8.4.1.1. Single Chamber Self Injectors
  - 8.4.1.2. Dual Chamber Self Injectors
- 8.4.2. Needle Free Injectors
  - 8.4.2.1. Pre Filled Needle Free Injectors
  - 8.4.2.2. Fill-Able Needle free Injectors
- 8.4.3. Auto Injectors
  - 8.4.3.1. Prefilled Auto Injectors
  - 8.4.3.2. Fill-Able Auto Injectors
- 8.4.4. Wearable Injectors
  - 8.4.4.1. Wearable Patch Injectors
  - 8.4.4.2. Off-body Worn Injectors
- 8.4.5. Insulin Pens
  - 8.4.5.1. Reusable Insulin Pens
  - 8.4.5.2. Disposable Insulin Pens
  - 8.4.5.3. Smart Insulin Pens
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
- 8.5.1. Non-Smart Injectors
- 8.5.2. Smart Injectors
  - 8.5.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
  - 8.5.2.2. Near Filed Communication (NFC)
  - 8.5.2.3. Cloud Computing
  - 8.5.2.4. Bluetooth
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Usage, 2025 - 2032
- 8.6.1. Disposable Injectors
- 8.6.2. Reusable Injectors
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
- 8.7.1. Anaphylaxis
- 8.7.2. Diabetes
- 8.7.3. Cardiovascular Diseases
- 8.7.4. Multiple Sclerosis
- 8.7.5. Rheumatoid Arthritis
- 8.7.6. Cancer
- 8.7.7. Trauma and Emergency
- 8.7.8. Others
8.8. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
- 8.8.1. Hospital Pharmacies
- 8.8.2. Drug Stores
- 8.8.3. Retail Pharmacies
- 8.8.4. Online Pharmacies
8.9. Market Attractiveness Analysis

9. South Asia & Oceania Injectable Drug Delivery Market Outlook

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Technology
- 9.2.4. By Usage
- 9.2.5. By Indication
- 9.2.6. By Distribution Channel
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
- 9.4.1. Self-Injectors
  - 9.4.1.1. Single Chamber Self Injectors
  - 9.4.1.2. Dual Chamber Self Injectors
- 9.4.2. Needle Free Injectors
  - 9.4.2.1. Pre Filled Needle Free Injectors
  - 9.4.2.2. Fill-Able Needle free Injectors
- 9.4.3. Auto Injectors
  - 9.4.3.1. Prefilled Auto Injectors
  - 9.4.3.2. Fill-Able Auto Injectors
- 9.4.4. Wearable Injectors
  - 9.4.4.1. Wearable Patch Injectors
  - 9.4.4.2. Off-body Worn Injectors
- 9.4.5. Insulin Pens
  - 9.4.5.1. Reusable Insulin Pens
  - 9.4.5.2. Disposable Insulin Pens
  - 9.4.5.3. Smart Insulin Pens
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
- 9.5.1. Non-Smart Injectors
- 9.5.2. Smart Injectors
  - 9.5.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
  - 9.5.2.2. Near Filed Communication (NFC)
  - 9.5.2.3. Cloud Computing
  - 9.5.2.4. Bluetooth
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Usage, 2025 - 2032
- 9.6.1. Disposable Injectors
- 9.6.2. Reusable Injectors
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
- 9.7.1. Anaphylaxis
- 9.7.2. Diabetes
- 9.7.3. Cardiovascular Diseases
- 9.7.4. Multiple Sclerosis
- 9.7.5. Rheumatoid Arthritis
- 9.7.6. Cancer
- 9.7.7. Trauma and Emergency
- 9.7.8. Others
9.8. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
- 9.8.1. Hospital Pharmacies
- 9.8.2. Drug Stores
- 9.8.3. Retail Pharmacies
- 9.8.4. Online Pharmacies
9.9. Market Attractiveness Analysis

10. Latin America Injectable Drug Delivery Market Outlook

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Technology
- 10.2.4. By Usage
- 10.2.5. By Indication
- 10.2.6. By Distribution Channel
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
- 10.4.1. Self-Injectors
  - 10.4.1.1. Single Chamber Self Injectors
  - 10.4.1.2. Dual Chamber Self Injectors
- 10.4.2. Needle Free Injectors
  - 10.4.2.1. Pre Filled Needle Free Injectors
  - 10.4.2.2. Fill-Able Needle free Injectors
- 10.4.3. Auto Injectors
  - 10.4.3.1. Prefilled Auto Injectors
  - 10.4.3.2. Fill-Able Auto Injectors
- 10.4.4. Wearable Injectors
  - 10.4.4.1. Wearable Patch Injectors
  - 10.4.4.2. Off-body Worn Injectors
- 10.4.5. Insulin Pens
  - 10.4.5.1. Reusable Insulin Pens
  - 10.4.5.2. Disposable Insulin Pens
  - 10.4.5.3. Smart Insulin Pens
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
- 10.5.1. Non-Smart Injectors
- 10.5.2. Smart Injectors
  - 10.5.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
  - 10.5.2.2. Near Filed Communication (NFC)
  - 10.5.2.3. Cloud Computing
  - 10.5.2.4. Bluetooth
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Usage, 2025 - 2032
- 10.6.1. Disposable Injectors
- 10.6.2. Reusable Injectors
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
- 10.7.1. Anaphylaxis
- 10.7.2. Diabetes
- 10.7.3. Cardiovascular Diseases
- 10.7.4. Multiple Sclerosis
- 10.7.5. Rheumatoid Arthritis
- 10.7.6. Cancer
- 10.7.7. Trauma and Emergency
- 10.7.8. Others
10.8. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
- 10.8.1. Hospital Pharmacies
- 10.8.2. Drug Stores
- 10.8.3. Retail Pharmacies
- 10.8.4. Online Pharmacies
10.9. Market Attractiveness Analysis

11. Middle East & Africa Injectable Drug Delivery Market Outlook

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Technology
- 11.2.4. By Usage
- 11.2.5. By Indication
- 11.2.6. By Distribution Channel
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025 - 2032
- 11.4.1. Self-Injectors
  - 11.4.1.1. Single Chamber Self Injectors
  - 11.4.1.2. Dual Chamber Self Injectors
- 11.4.2. Needle Free Injectors
  - 11.4.2.1. Pre Filled Needle Free Injectors
  - 11.4.2.2. Fill-Able Needle free Injectors
- 11.4.3. Auto Injectors
  - 11.4.3.1. Prefilled Auto Injectors
  - 11.4.3.2. Fill-Able Auto Injectors
- 11.4.4. Wearable Injectors
  - 11.4.4.1. Wearable Patch Injectors
  - 11.4.4.2. Off-body Worn Injectors
- 11.4.5. Insulin Pens
  - 11.4.5.1. Reusable Insulin Pens
  - 11.4.5.2. Disposable Insulin Pens
  - 11.4.5.3. Smart Insulin Pens
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
- 11.5.1. Non-Smart Injectors
- 11.5.2. Smart Injectors
  - 11.5.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
  - 11.5.2.2. Near Filed Communication (NFC)
  - 11.5.2.3. Cloud Computing
  - 11.5.2.4. Bluetooth
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Usage, 2025 - 2032
- 11.6.1. Disposable Injectors
- 11.6.2. Reusable Injectors
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
- 11.7.1. Anaphylaxis
- 11.7.2. Diabetes
- 11.7.3. Cardiovascular Diseases
- 11.7.4. Multiple Sclerosis
- 11.7.5. Rheumatoid Arthritis
- 11.7.6. Cancer
- 11.7.7. Trauma and Emergency
- 11.7.8. Others
11.8. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
- 11.8.1. Hospital Pharmacies
- 11.8.2. Drug Stores
- 11.8.3. Retail Pharmacies
- 11.8.4. Online Pharmacies
11.9. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2025
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Eli Lilly and Company
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. Biocon
- 12.3.3. Becton, Dickinson & Company
- 12.3.4. West Pharmaceutical Services, Inc.
- 12.3.5. Johnson & Johnson
- 12.3.6. Antares Pharma
- 12.3.7. AbbVie Inc.
- 12.3.8. Pfizer Inc.
- 12.3.9. Mylan N.V.
- 12.3.10. Vetter Pharma-Fertigung GmbH & Co.KG
- 12.3.11. Emperra GmbH
- 12.3.12. Digital Medics Pty Ltd
- 12.3.13. Enable Injections LLC
- 12.3.14. Insulet corporation
- 12.3.15. Consort Medical Plc.
- 12.3.16. Diabnext
- 12.3.17. Diamesco Co., Ltd
- 12.3.18. SCHOTT AG (Schott Kaisha Pvt. Ltd.)
- 12.3.19. SiO2 Medical Products
- 12.3.20. Integrity Bio, Inc.
- 12.3.21. Wilhelm Haselmeier GmbH & Co. KG
- 12.3.22. Tandem Diabetes Care
- 12.3.23. Sanofi S.A.
- 12.3.24. Companion Medical Inc.
- 12.3.25. Ypsomed
- 12.3.26. F. Hoffman - La Roche Ltd.
- 12.3.27. Novo Nordisk A/S
- 12.3.28. Medtronic Plc.

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations